Back to Search
Start Over
Hepatitis B therapy, hepatocellular carcinoma and HBsAg mutants.
- Source :
-
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2013 Jun; Vol. 45 (6), pp. 525-7. Date of Electronic Publication: 2013 Feb 15. - Publication Year :
- 2013
- Subjects :
- Adenine adverse effects
Adenine analogs & derivatives
Adenine therapeutic use
Antiviral Agents therapeutic use
Carcinoma, Hepatocellular diagnosis
Carcinoma, Hepatocellular immunology
Carcinoma, Hepatocellular surgery
DNA, Viral blood
Drug Therapy, Combination
Hepatitis B blood
Humans
Immunohistochemistry
Lamivudine adverse effects
Lamivudine therapeutic use
Liver Neoplasms diagnosis
Liver Neoplasms immunology
Liver Neoplasms surgery
Male
Middle Aged
Organophosphonates adverse effects
Organophosphonates therapeutic use
Real-Time Polymerase Chain Reaction
Tomography, X-Ray Computed
Antiviral Agents adverse effects
Carcinoma, Hepatocellular chemically induced
Hepatitis B drug therapy
Hepatitis B Surface Antigens analysis
Liver Neoplasms chemically induced
Subjects
Details
- Language :
- English
- ISSN :
- 1878-3562
- Volume :
- 45
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
- Publication Type :
- Report
- Accession number :
- 23415581
- Full Text :
- https://doi.org/10.1016/j.dld.2013.01.011